Sensible Biotechnologies raises $47M led by Oxford Science.

<div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <p>Sensible Biotechnologies raises $47M led by Oxford Science.</p><p>Sensible Biotechnologies develops provider of an integrated mRNA technology platform. The company is led by CEO Miroslav Gasparek.</p><table class="vc-deal-terms"><tbody><tr><th>Company</th><td>Sensible Biotechnologies</td></tr><tr><th>Amount</th><td>$47M</td></tr><tr><th>Lead Investor</th><td>Oxford Science</td></tr><tr><th>Founders</th><td>Miroslav Gasparek</td></tr><tr><th>Sectors</th><td>Biotechnology</td></tr></tbody></table>
</div>
</div>
</div>


<div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <p>Sensible Biotechnologies raises <strong>$47M</strong> led by Oxford Science.</p>
<p>Sensible Biotechnologies develops provider of an integrated mRNA technology platform. The company is led by CEO Miroslav Gasparek.</p>
<table class="vc-deal-terms"><tbody>
<tr>
<th>Company</th>
<td>Sensible Biotechnologies</td>
</tr>
<tr>
<th>Amount</th>
<td><strong>$47M</strong></td>
</tr>
<tr>
<th>Lead Investor</th>
<td>Oxford Science</td>
</tr>
<tr>
<th>Founders</th>
<td>Miroslav Gasparek</td>
</tr>
<tr>
<th>Sectors</th>
<td>Biotechnology</td>
</tr>
</tbody></table>
</div>
</div>
</div>


Sensible Biotechnologies Raises $47M From Oxford Science

Sensible Biotechnologies Raises $47M From Oxford Science | Traded VC

ABOUT THIS STORY

<div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <p>Sensible Biotechnologies raises <strong>$47M</strong> led by Oxford Science.</p>
<p>Sensible Biotechnologies develops provider of an integrated mRNA technology platform. The company is led by CEO Miroslav Gasparek.</p>
<table class="vc-deal-terms"><tbody>
<tr>
<th>Company</th>
<td>Sensible Biotechnologies</td>
</tr>
<tr>
<th>Amount</th>
<td><strong>$47M</strong></td>
</tr>
<tr>
<th>Lead Investor</th>
<td>Oxford Science</td>
</tr>
<tr>
<th>Founders</th>
<td>Miroslav Gasparek</td>
</tr>
<tr>
<th>Sectors</th>
<td>Biotechnology</td>
</tr>
</tbody></table>
</div>
</div>
</div>

Sensible Biotechnologies Raises $47M From Oxford Science

ABOUT THIS STORY

Siena Raises $17M

Avarra Raises $17M From Firstmark Capital

Vinci Raises $250M at $1.5B Valuation

Company	Sensible Biotechnologies
Amount	$47M
Lead Investor	Oxford Science
Founders	Miroslav Gasparek
Sectors	Biotechnology

Sensible Biotechnologies Raises $47M From Oxford Science

ABOUT THIS STORY

More articles

Siena Raises $17M

Avarra Raises $17M From Firstmark Capital

Vinci Raises $250M at $1.5B Valuation